<code id='6307C901E7'></code><style id='6307C901E7'></style>
    • <acronym id='6307C901E7'></acronym>
      <center id='6307C901E7'><center id='6307C901E7'><tfoot id='6307C901E7'></tfoot></center><abbr id='6307C901E7'><dir id='6307C901E7'><tfoot id='6307C901E7'></tfoot><noframes id='6307C901E7'>

    • <optgroup id='6307C901E7'><strike id='6307C901E7'><sup id='6307C901E7'></sup></strike><code id='6307C901E7'></code></optgroup>
        1. <b id='6307C901E7'><label id='6307C901E7'><select id='6307C901E7'><dt id='6307C901E7'><span id='6307C901E7'></span></dt></select></label></b><u id='6307C901E7'></u>
          <i id='6307C901E7'><strike id='6307C901E7'><tt id='6307C901E7'><pre id='6307C901E7'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:7
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          FDA panel to weigh safety of artificial wombs for preterm births
          FDA panel to weigh safety of artificial wombs for preterm births

          AdobeTheartificialwomb,adeviceaimingtosaveinfantsbornwaytoosoon,isinchingclosertobeingtestedinhumans

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Idaho abortion case may prompt more restrictions in other states

          DrewAngerer/GettyImagesTheU.S.SupremeCourt’sdecisiontoconsiderthelegalityofIdaho’sabortionlaw—andtor